Stay updated on Cabozantinib & 13-cisRA in Children Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.

Latest updates to the Cabozantinib & 13-cisRA in Children Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check57 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a clinical trial involving cabozantinib and 13-cis-retinoic acid, while adding references to collaborators and a new version revision number.SummaryDifference45%
- Check65 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check108 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to Cabozantinib & 13-cisRA in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.